RIA
ALXN

Realta Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Realta Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51
Closed -$5K – 1565
2019
Q4 		$5K Hold
51
– – ﹤0.01% 1361
2019
Q3 		$5K Buy
+51
New +$5.75K ﹤0.01% 1350
2019
Q2 		– Sell
-60
Closed -$8K – 1851
2019
Q1 		$8K Buy
+60
New +$7.46K ﹤0.01% 983

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Realta Investment Advisors's ALXN Position: Q1 2020 in Review

Realta Investment Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 51 shares — an estimated $5K sold.

Realta Investment Advisors first reported a position in ALXN in Q1 2019 and held it in 3 quarters. The position peaked at $8K in Q1 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Realta Investment Advisors reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 51 Alexion Pharmaceuticals shares in Q1 2020, an estimated $5K.
  • Realta Investment Advisors first reported a position in Alexion Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Realta Investment Advisors's Alexion Pharmaceuticals position peaked at $8K in Q1 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.